Maintenance therapy with subcutaneous imsidolimab allowed all treated patients to remain flare-free throughout the GEMINI-2 study period.

The patient described earlier highlights important clinical points regarding the complex management of psoriasis. First, we must recognize that her obesity, hypertension, dyslipidemia, and non-insulin ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Should you see ...

Evidence from multiple trials links weight loss with milder symptoms and improved wellbeing in people with psoriasis.

Posters presented at the American Academy of Dermatology Annual Meeting identified significant undertreatment of psoriasis and significant gaps in biologic medication treatment. This content was ...

The results of 2 recent clinical trials combining the GLP-1 drug and the biologic reinforce the benefits of treating obesity and inflammation together.

Linda Stein Gold, MD, director of dermatology clinical research and division head of dermatology at Henry Ford Health System, discussed some “exciting talks” from Maui Derm 2026 that focused on oral ...

The realities of living with psoriasis go beyond the physical and mental symptoms of itchy and painful skin, sleep issues, and depression. Psoriasis can also have a financial impact. Steroids and ...

Why aren't we talking about it more?

Psoriasis is a complex immune-mediated disease that affects approximately 120 million people globally and requires chronic management. 1 The condition manifests itself in the skin, joints, or both, ...

Add Yahoo as a preferred source to see more of our stories on Google. Everyone's skin reacts differently to the changing seasons. Recent studies show about 30% of psoriasis patients saw improvement ...